Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Altimmune (ALT) Receivables - Net (2016 - 2025)

Altimmune (ALT) has disclosed Receivables - Net for 16 consecutive years, with $845000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net rose 97.43% to $845000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $845000.0, a 97.43% increase, with the full-year FY2024 number at $544000.0, down 51.04% from a year prior.
  • Receivables - Net was $845000.0 for Q3 2025 at Altimmune, up from $321000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $4.8 million in Q1 2021 to a low of $136000.0 in Q2 2023.
  • A 5-year average of $958559.5 and a median of $429000.0 in 2021 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: tumbled 95.98% in 2022, then soared 542.2% in 2023.
  • Altimmune's Receivables - Net stood at $429000.0 in 2021, then plummeted by 59.67% to $173000.0 in 2022, then skyrocketed by 542.2% to $1.1 million in 2023, then tumbled by 51.04% to $544000.0 in 2024, then surged by 55.33% to $845000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALT's Receivables - Net are $845000.0 (Q3 2025), $321000.0 (Q2 2025), and $507000.0 (Q1 2025).